Three-year results of the MOTION randomized controlled trial for treatment of lumbar spinal stenosis using the percutaneous mild® Procedure

MOTION 3-year follow-up results continue to demonstrate the safety and durability of the <i>mild</i> Procedure combined with CMM for early interventional treatment of symptomatic LSS. The absence of device or procedure-related adverse events further underscores the robust safety profile of the <i>mild</i> Procedure. Significant and substantial improvements in all the outcomes were observed from baseline to follow-up for patients treated with the <i>mild</i> Procedure. These results support the <i>mild</i> Procedure as an effective approach for early intervention in LSS treatment.